NCT05442281

Brief Summary

Following increased knowledge about climate change and how food production affects greenhouse gas emissions, the interest in vegetarian diets is increasing. In line with this, also vegan diet is becoming more common at all ages, including in young children. But the state of knowledge regarding the effect of this diet on children during infancy and early childhood has been poorly studied and existing literature consists to a large extent of case reports. With the main hypothesis that vegan diet from the introduction of complementary foods causes reduced bio availability of certain micronutrients important for development, the aim of this study is to examine dietary intake and development during the first years of life in a group of children eating vegan diet and compare with a reference group eating mixed diets. In an observational study, investigators plan to include 30 children before the age of 6 months during the years 2021-2026, where the parents have decided to offer their child only vegan food. The children are studied in comparison with a reference group of 30 matched cases regarding growth, nutritional status, and dietary intake. Data collection includes monthly dietary records and blood sample analyses and growth at 6, 12 and 24 months. At the age of 3, cognitive developmental assessment (WPSSI-IV) and an DEXA examination of body composition are performed. The study is expected to contribute to increased knowledge about the risk and benefits of vegan diets and thereby provide a better basis for future recommendations.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
44mo left

Started Sep 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Sep 2021Dec 2029

Study Start

First participant enrolled

September 1, 2021

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 23, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 1, 2022

Completed
6.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2029

Last Updated

May 16, 2024

Status Verified

May 1, 2024

Enrollment Period

7.3 years

First QC Date

May 23, 2022

Last Update Submit

May 15, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Concentration of Hemoglobin

    Blood

    12 months of age

  • Body Weight (kg)

    measured weight at 12 mo using a device for measuring weight

    12 months of age

Secondary Outcomes (18)

  • Wechsler Preschool & Primary Scale of Intelligence

    3 years of age

  • Fat mass index

    3 years of age

  • Lean mass index

    3 years of age

  • Protein intake

    at 12 months of age

  • Fat intake

    at 12 months of age

  • +13 more secondary outcomes

Study Arms (2)

Vegan diet

Children fed vegan diet from 6 months of life

Mixed diet

Children fed mixed diet from 6 months of life

Eligibility Criteria

Age4 Months - 8 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Swedish infants mainly breastfed planned for vegan or mixed diet respectively

You may qualify if:

  • Planned exclusive vegan diet or mixed diet respectively from 6 months of age until at least 2 years of life
  • Exclusively (\>90%) breastfed until 4 months
  • Born term (GE 37+0 - 41+6)
  • Single birth
  • Birth weight \>2500 g
  • Apgar score 5 min \> 5

You may not qualify if:

  • \* A chronic disease affecting growth or neurodevelopment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Umeå University, Department of Clinical Sciences

Umeå, 90185, Sweden

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum, breast milk, whole blood

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Consultant, associate professor

Study Record Dates

First Submitted

May 23, 2022

First Posted

July 1, 2022

Study Start

September 1, 2021

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2029

Last Updated

May 16, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations